Of particular relevance are the rapidly accelerating fibrosarcoma (RAF) family of serine/threonine kinases that are commonly mutated in many human cancer types including colorectal, thyroid, and non–small cell lung cancers (NSCLC), melanoma, and gliomas (7, 8). This evidence concerns the gene RAF1 and non-small cell lung carcinoma.